Stay updated on LTI-03 Safety & PK in Healthy Adults Clinical Trial
Sign up to get notified when there's something new on the LTI-03 Safety & PK in Healthy Adults Clinical Trial page.

Latest updates to the LTI-03 Safety & PK in Healthy Adults Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now displays the completed Phase 1 study of inhaled LTI-03, including its study design, dose cohorts, eligibility criteria, location, and safety outcome measure.SummaryDifference51%

- Check20 days agoChange DetectedThe site revision in the footer changed from v3.7.2 to v3.8.0. The page continues to show a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check27 days agoChange DetectedA banner announces an NIH website terminology transition, stating that “Super Intelligence” will replace “Artificial Intelligence” across NIH content.SummaryDifference1%

- Check34 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check41 days agoChange DetectedThe footer revision identifier was updated from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check62 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record content, indicating restricted access to this ClinicalTrials.gov entry. This means the study details are not accessible at this moment.SummaryDifference19%

Stay in the know with updates to LTI-03 Safety & PK in Healthy Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LTI-03 Safety & PK in Healthy Adults Clinical Trial page.